MedPath
NMPA Approval

Nitric Oxide for Inhalation

国药准字HJ20220015

March 8, 2022

Drug Information

吸入用一氧化氮

吸入制剂

800ppm

化学药品

March 8, 2022

March 7, 2027

Company Information

Applicant Company

440 Route 22 East, Bridgewater, NJ 08807 United States of America

Manufacturing Company

1060 Allendale Drive, Port Allen, LA 70767 United States of America

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

吸入用一氧化氮 - NMPA 批准文号 | MedPath